Unknown

Dataset Information

0

Retrospective Analysis of Treatment Patterns in Pseudophakic Diabetic Macular Oedema Eyes Treated with Anti-VEGF.


ABSTRACT:

Methods

We performed a retrospective review of outcomes in 81 pseudophakic eyes with DMO that received at least 6 anti-VEGF injections. We reviewed baseline and posttreatment optical coherence tomography images, visual acuity, prescribing patterns, time taken to deliver anti-VEGF injections, and structural and functional outcomes.

Results

It took an average of 913 ± 454.1 days to deliver a mean of 11.1 ± 4.7 anti-VEGF injections. Time from baseline to receiving the first 6 anti-VEGF injections was longer than 9 months in 74.7% (n = 59/79) of eyes. There was a mean gain of 1.6 letters (-0.03 logMAR) from baseline to the end point. After 5 anti-VEGF intravitreal injections, the mean CMT was 391.9 μm from 474.4 μm at baseline (p < 0.0001). In 52 of 79 eyes (65.8%), more than one type of anti-VEGF agent was used.

Conclusions

The anti-VEGF treatment used to treat these eyes with DMO was suboptimal, a finding consistent with recently published "real-world" data. There was a strong tendency for patients to be switched within the class to a second anti-VEGF agent.

SUBMITTER: Zou D 

PROVIDER: S-EPMC8337101 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC9232615 | biostudies-literature
| S-EPMC9694649 | biostudies-literature
| S-EPMC3729702 | biostudies-literature
| S-EPMC3987934 | biostudies-other
| S-EPMC6494419 | biostudies-literature
| S-EPMC6481463 | biostudies-literature
| S-EPMC6517135 | biostudies-literature
| S-EPMC6516994 | biostudies-literature
| S-EPMC7563612 | biostudies-literature
| S-EPMC5328320 | biostudies-literature